Approval · Notice of Compliance 183 · 2004
LEVITRA: Notice of Compliance 183
Issued March 17, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 183
- Date
- March 17, 2004
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Cyclic gmp-specific phosphodiesterase type 5 inhibitor
Products in this notice
Medicinal ingredients
- VARDENAFIL HYDROCHLORIDE 5 MG per TAB
- VARDENAFIL HYDROCHLORIDE 10 MG per TAB
- VARDENAFIL HYDROCHLORIDE 20 MG per TAB